Constellation Energy Corporation vs BIO-TECHNE Corp — how do they compare? Constellation Energy Corporation trades at $257.9 (market cap $91.98B), while BIO-TECHNE Corp trades at $71.23 (market cap $11.12B). The key difference: Constellation Energy Corporation is far larger — about 8.3× BIO-TECHNE Corp's market cap, and Constellation Energy Corporation pays the higher dividend (0.66%). Which is the better fit depends on your goals.
| CEG | TECH | |
|---|---|---|
Market Cap | $91.98B | $11.12B |
Sector | Energy | Health |
52-Week High | $403.95 | $71.38 |
52-Week Low | $236.50 | $43.31 |
Enterprise Value | $113.64B | $11.20B |
Dividend Yield | 0.66% | 0.45% |
Trailing returns across standard periods
Latest headlines on both assets
Constellation is the largest producer of carbon-free energy in the U.S. and a leading nuclear power plant operator. It provides sustainable electricity to millions of residential, public, and industrial customers.
Read more on CEG →Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →